l-carnitine tmao nature medicine 2013 koeth TMAO: how gut microbiota contributes to heart failure The gut–brain axis and trimethylamine
The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Gut microbiota derived metabolites in cardiovascular health and disease Protein & Cell Springer Nature Link
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




